MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer | |
Xie, Manxin; Fu, Ziyi; Cao, Jianxiang; Liu, Yuan; Wu, Jie; Li, Qing; Chen, Yun | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY |
2018 | |
卷号 | 102 |
关键词 | Breast cancer microRNA miR-132 miR-212 PTEN |
ISSN号 | 0753-3322 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4265970 |
专题 | 上海健康医学院 |
推荐引用方式 GB/T 7714 | Xie, Manxin,Fu, Ziyi,Cao, Jianxiang,et al. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,102. |
APA | Xie, Manxin.,Fu, Ziyi.,Cao, Jianxiang.,Liu, Yuan.,Wu, Jie.,...&Chen, Yun.(2018).MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer.BIOMEDICINE & PHARMACOTHERAPY,102. |
MLA | Xie, Manxin,et al."MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer".BIOMEDICINE & PHARMACOTHERAPY 102(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论